---
figid: PMC10309536__po-7-e2200653-g002
pmcid: PMC10309536
image_filename: po-7-e2200653-g002.jpg
figure_link: /pmc/articles/PMC10309536/figure/fig2/
number: FIG 2
figure_title: ''
caption: Immortal time bias of OS. (A) OS of patients enrolled in the overall population
  and patients enrolled after and before the initiation of first-line treatment. (B)
  Schematic of immortal time bias in clinical sequencing studies. Patients who died
  before genomic profiling would never have been enrolled. (C) Hazard ratio of the
  OS of patients enrolled after versus before the initiation of first-line treatment.
  GIST, gastrointestinal stromal tumor; NE, not evaluated; NR, not reached; OS, overall
  survival.
article_title: 'Efficacy of Targeted Trials and Signaling Pathway Landscape in Advanced
  Gastrointestinal Cancers From SCRUM-Japan GI-SCREEN: A Nationwide Genomic Profiling
  Program.'
citation: Yoshiaki Nakamura, et al. JCO Precis Oncol. 2023;7:e2200653.
year: '2023'

doi: 10.1200/PO.22.00653
journal_title: JCO Precision Oncology
journal_nlm_ta: JCO Precis Oncol
publisher_name: Wolters Kluwer Health

keywords:
---
